One in six Americans who have ever taken a prescription drug experienced a side effect serious enough to send them to the doctor or hospital, but the majority of consumers don't know they can report these side effects to the
Recently named one of the fastest growing private small businesses in Oregon and a top diversity-owned business, this health education and communications firm serves pharmaceutical and food and beverage industries (PRWeb Apr 3, 2008) Read the full story at http://ww1.prweb.com/releases/2008/04/prweb828064.htm
BioTime, Inc. (OTCBB:BTIM) and its wholly-owned subsidiary Embryome Sciences, Inc., have signed a letter of intent with International Stem Cell Corporation (OTCBB:ISCO) and its wholly-owned subsidiary Lifeline Cell Technology (Lifeline) to jointly produce and distribute a wide array of research
PsychoGenics Inc., announced the appointment of Mark Day, Ph.D., as Senior Director, Cognitive Neuroscience. This appointment reflects the company's expansion and commitment to the cognitive neurosciences. (PRWeb Apr 3, 2008) Read the full story at
Study from Supply Today finds that data and communication can fix damaged relationships with third-party warehouse and logistics providers. (PRWeb Apr 3, 2008) Read the full story at http://ww1.prweb.com/releases/2008/04/prweb814774.htm
Americans for Cures Foundation is proud to announce that Carlana Stone, a star of Oprah Winfrey's "Big Give," will be speaking at its first State of Stem Cell Advocacy (SOSCA) Conference on April 12-13 at the UCSF Mission Bay Conference
Merck & Co. has said that, in a Phase III pilot dose-ranging study of patients with acute heart failure syndrome and renal impairment, treatment with rolofylline administered with intravenous loop diuretics was associated with improved dyspnea and preserved renal function
Vivus has successfully completed and reached agreement with the FDA regarding the special protocol assessment for the Phase III efficacy trials for Luramist for the treatment of hypoactive sexual desire disorder or low libido in women.
BioDelivery Sciences International has reported that Meda has submitted a dossier seeking approval to market Bema Fentanyl for the treatment of breakthrough pain in opioid tolerant cancer patients to the German Federal Institute for Drugs and Medical Devices.
Cardinal Health has signed an agreement with ClearCount Medical Solutions to distribute SmartSponge system that integrates both counting and detection for sponge management during surgeries.
Evalve has reported positive results from Everest trial, which showed that percutaneous mitral repair using the MitraClip device may successfully reduce mitral regurgitation in patients suffering from functional mitral regurgitation over a two-year period.
Medical device company Interventional Spine has appointed Harold Hurwitz to the newly created position of CFO, reporting to Walter Cuevas, CEO of the company.
Swedish medical technology company Sectra has signed a distribution agreement with the Japanese company Medical Expert, a provider of medical imaging products.
WaferGen Biosystems has signed an exclusive distribution agreement for the company's SmartSlide Micro-Incubation System with IUL Instruments in Germany.
ChemGenex Pharmaceuticals has reported positive interim results from the company's ongoing Phase II/III trial of omacetaxine mepesuccinate in chronic myeloid leukemia patients with the T315I mutation.
Cardium Therapeutics has reported that its operating unit InnerCool Therapies has entered into a European commercialization agreement with Euromed Medizinisch, a distributor of cardiology medical products.
Cleveland BioLabs has reported that the recent primate studies have demonstrated the efficacy of the company's Protectan CBLB502 as a mitigator of hematopoietic damage up to 48 hours post radiation exposure.
